We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 301 start-ups with an aggregate funding of $8.9b. The average funding per company in this subset is $129.2m.
Last update to the database: Feb 18, 2025. See changelog.
Arzeda is a biotechnology and software company designing custom microorganisms for industrial applications through computational enzyme design, protein optimization, and metabolic engineering.
5
Funding Rounds
$72.2m
Money raised
A genetic medicine company that build data platforms using synthetic biology, artificial intelligence and genetic medicine for the development of medical therapies.
5
Funding Rounds
$236.7m
Money raised
Owkin is a medical treatment and therapeutics company founded by Thomas Clozel. They develop artificial intelligence and machine learning tools to augment and develop medical and biological research.
7
Funding Rounds
$254.1m
Money raised
PathAI is a Boston-based artificial intelligence company developing therapeutics and healthcare products.
5
Funding Rounds
$390.0m
Money raised
Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases
6
Funding Rounds
$356.3m
Money raised
Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.
10
Funding Rounds
$930.0m
Money raised
UBiome was a biotechnology microbial genomics company based in San Francisco.
8
Funding Rounds
$111.4m
Money raised
Notable Labs is a company providing personalized drug combination testing service for cancer patients.
8
Funding Rounds
$71.3m
Money raised
Aria Pharmaceuticals is a first-in-class pharmaceutical discovery and development founded in 2014 by Andrew M. Radin.
3
Funding Rounds
$14.3m
Money raised
Orbit Discovery offers a DNA-encoded peptide display technology to identify potential peptide drugs for a range of chronic diseases.
2
Funding Rounds
$16.8m
Money raised
BenchSci is a biotechnology company with a machine learning platform for researching biological compounds. It was founded in 2015 and is located in Toronto, Canada.
6
Funding Rounds
$83.3m
Money raised
A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018.
4
Funding Rounds
$153.7m
Money raised
Inato matches the right sites to the right clinical research study, globally.
4
Funding Rounds
$49.6m
Money raised
Paige provides AI-based digital diagnostics and a vendor-neutral platform designed to drive diagnostic confidence and a more productive pathology workflow.
10
Funding Rounds
$410.0m
Money raised
Antidote.me closes the gap between clinical trials and patients
5
Funding Rounds
$28.9m
Money raised
Trials.ai is an artificial intelligence company founded by Kim Walpole and Tom Walpole.
4
Funding Rounds
AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.
4
Funding Rounds
$76.3m
Money raised
Massive Bio is a New York-based company founded by Selin Kurnaz, Dr. Arturo Loaiza-Bonilla and Cagatay M. Culcuoglu, offering precision oncology services to cancer patients, providers, and pharmaceutical companies.
6
Funding Rounds
$15.8m
Money raised
Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.
9
Funding Rounds
$82.6m
Money raised
A company developing anti-aging treatments using components derived from human blood.
3
Funding Rounds
$41.0m
Money raised
Synthetic biology company that uses AI, DNA synthesis, and robotics to discover biological molecules.
8
Funding Rounds
$101.4m
Money raised
OrphAI Therapeutics is a biotechnology research company based in Guilford, Connecticut that develops precision therapeutics technology designed to treat cancer and rare diseases.
2
Funding Rounds
$98.0m
Money raised
Envisagenics is a biotechnology company founded by Maria Luisa Pineda and Martin Akerman in 2014 and headquartered in New York City, New York using artificial intelligence and RNA sequencing to develop therapeutics to treat genetic diseases.
9
Funding Rounds
$26.8m
Money raised
Sanofi Pasteur is a manufacturer of vaccines and related products founded in 1914 by Marcel Mérieux.
1
Funding Rounds
$43.2m
Money raised
Sherlock Biosciences is a Cambridge, Massachusetts-based company founded in 2019 by David R. Walt, Rahul Dhanda, Feng Zhang, Jim Collins, Deborah Hung, Jonathan Gootenberg, Omar Abudayyeh, Pardis Sabeti and Todd Golub.
4
Funding Rounds
$153.5m
Money raised
Deep Lens is an Artificial Intelligence company matching patients with clinical trials.
3
Funding Rounds
$31.2m
Money raised
A therapeutics company founded in 2016 working in drug discovery and development using fungi. LifeMine uses genomics approaches to search for biosynthetic genes in eukaryotic microbes for the discovery of naturally inspired drugs to treat previously untreatable and significant chronic diseases.
3
Funding Rounds
$280.0m
Money raised
Athelas is a company developing blood testing device that utilizes deep learning and computer vision.
5
Funding Rounds
$155.6m
Money raised
Clinithink is a Natural Language Processing AI for structuring medical chart notations
3
Funding Rounds
Deep 6 AI is an artificial Intelligence company founded by Wout Brusselaers.
3
Funding Rounds
$34.0m
Money raised
GNS Healthcare is a data analytics and healthcare company. It was founded in 2000 and is located in Cambridge, Massachusetts.
4
Funding Rounds
$44.0m
Money raised
Lung Therapeutics is a therapeutics for lung injury and disease company founded in 2013 by Andrew Mazar, Steven Idell and Sreerama Shetty.
2
Funding Rounds
$50.3m
Money raised
Nutritas is a biotechnology company using artificial intelligence to help discover bioactive peptides.
1
Funding Rounds
$65.0m
Money raised
A bioinformatics company in San Francisco building data collection methods and databases that will enable machine learning algorithms in healthcare. It was founded in 2018.
4
Funding Rounds
$743.2m
Money raised
ThoughtSpot is a business intelligence platform for exploring, analyzing, and sharing real-time business analytics data.
6
Funding Rounds
$613.7m
Money raised
Emergex aims to tackle the global threat of infectious disease by providing affordable and practical on-demand vaccine solutions.
2
Funding Rounds
$11.3m
Money raised
Ichor Therapeutics is a pre-clinical contract research on aging mechanisms company founded in 2013 by Kelsey Moody.
5
Funding Rounds
$2.5m
Money raised
Leader in delivering real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.
6
Funding Rounds
$230.6m
Money raised
A software-as-a-service technology company with a focus on robotic solutions for laboratories. It was founded in 2019 and is located in Menlo Park, California.
8
Funding Rounds
$100.4m
Money raised
A company with an explainable artificial intelligence platform that can analyze data for government, financial services, and healthcare. It was founded in 2014 and is located in San Mateo, California.
9
Funding Rounds
$28.5m
Money raised
3T Biosciences is a biotechnology company developing immunotherapies.
3
Funding Rounds
$52.0m
Money raised
Mendel.ai is a life science company offering an artificial intelligence platform to aid clinical experts improve their clinical cancer research.
7
Funding Rounds
$65.4m
Money raised
An enterprise software company developing computer aided design (CAD) tools for designing and testing DNA sequences.
4
Funding Rounds
$3.3m
Money raised
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
4
Funding Rounds
$7.1m
Money raised
Biotechnology company using Artificial Intelligence to discover drugs by translating life sciences big data into therapies
1
Funding Rounds
$3.5m
Money raised
Dyno Therapeutics is a company based in Cambridge, Massachusetts applying artificial intelligence to gene therapy, focused on adeno-associated virus capsid engineering.
3
Funding Rounds
$109.0m
Money raised
Terray Therapeutics is a Los Angeles-based biotechnology company that combines ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology to explore molecules and their targets for the purpose of discovering and developing small molecule therapeutics.
2
Funding Rounds
$180.0m
Money raised
Peptome is a London-based protein physics intelligence company founded in 2016 by Kamil Tamiola and Matt Heberling. It utilizes artificial intelligence for computers to process all information about protein data in the same efficient way that scientists do.
5
Funding Rounds
$82.8m
Money raised
Oxford Drug Design Limited is a company that focuses on developing and delivering services and technologies for computer-aided drug discovery
5
Funding Rounds
$10.0m
Money raised
A biopharmaceutical company developing neurobehavioural therapeutic treatments using artificial intelligence and clinical neuroscience.
5
Funding Rounds
$228.0m
Money raised
Palvella Therapeutics is committed to developing safe and effective therapies that specifically target the root cause of genetic skin diseases.
2
Funding Rounds
$55.0m
Money raised
A biotechnology company using mass spectrometry platforms for drug discovery and the development of therapeutics.
1
Funding Rounds
$100.0m
Money raised
An artificial intelligence company with a focus on developing solutions for the healthcare industry. It was founded in 2017 and is located in Tel Aviv, Israel.
2
Funding Rounds
$11.5m
Money raised
Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.
4
Funding Rounds
$46.7m
Money raised
Nuclera is a provider of eProtein discovery benchtop system founded in 2013 by Jiahao Huang, Gordon McInroy and Michael Chen.
3
Funding Rounds
$133.0m
Money raised
Biofourmis is a global health IT start-up in Massachusetts that focuses on personalized care and therapies using digital therapeutics.
7
Funding Rounds
$443.5m
Money raised
A biopharmaceutical company focused on developing treatments for urea cycle disorders and other rare diseases
3
Funding Rounds
$117.5m
Money raised
Reify Health is a company building healthcare system
6
Funding Rounds
$478.8m
Money raised
Artificial intelligence company specializing in big data analysis of scientific and technical literature.
2
Funding Rounds
$9.0m
Money raised
Horizon Discovery is a company that offers gene editing, CRO, and diagnostics services
5
Funding Rounds
$30.9m
Money raised
doc.ai is a Los Altos, California-based AI company for deep learning on quantitative biology founded by Walter De Brouwer, Anthea Chung, Sam De Brouwer, and Alan Greene.
6
Funding Rounds
$41.0m
Money raised
Synthetic biology company that created novel DNA base pairs and uses them to incorporate novel amino acids into proteins for potential therapeutics in areas of cancer and autoimmune disorders.
5
Funding Rounds
$152.0m
Money raised
64x Bio is a biotechnology company developing a platform for improving speed and scalability of mammalian cell line discovery for pharmaceutical and biotechnology companies.
3
Funding Rounds
$59.5m
Money raised
Forcyte Biotechnologies is a Los Angeles-based biotechnology company, founded in 2017.
4
Funding Rounds
$185.0k
Money raised
AI-powered drug discovery platform.
3
Funding Rounds
$69.5m
Money raised
A biotechnology company developing immune-modulation therapies for infectious diseases and cancer leveraging its technology platform and understanding of immune system mechanisms. It was founded in 2009 and is located in Vienna, Austria.
3
Funding Rounds
$68.0m
Money raised
Genecentric Diagnostics, Inc. is an oncology diagnostic and treatment center.
4
Funding Rounds
$13.9m
Money raised
A bio-data company that uses AI to analyze RNA sequencing data
2
Funding Rounds
$5.4m
Money raised
Verge Genomics is a company focused on the discovery and development of drugs for the treatment of neurodegenerative diseases with the use of machine learning and computational genomics.
5
Funding Rounds
$134.1m
Money raised